4 Referanser

• ^[1] Zeeb H, Shannoun F, red. WHO handbook on indoor radon: a public health perspective. Genève: World Health Organization, 2009. WHO handbook on indoor radon: a public health perspective (23.09.2025)
• ^[2] Hassfjell C S, Grimsrud T K, Standring W J F, Steinar T. Lungekreftforekomst knyttet til radoneksponering i norske boliger. Tidsskrift for Den norske legeforening 2017; nr. 14/15. doi:10.4045/tidsskr.16.0127 https://tidsskriftet.no/2017/08/originalartikkel/lungekreftforekomst-knyttet-til-radoneksponering-i-norske-boliger (13.12.2021)
• ^[3] Cancer in Norway 2022 – Cancer incidence, mortality, survival and prevalence in Norway. Oslo: Cancer Registry of Norway, 2023.https://www.fhi.no/globalassets/cancer-in-norway/2022/cin_report-2022.pdf (23.9.2025)
• ^[4] WHO, nettside. Radon and health. World Health Organization (WHO). https://www.who.int/news-room/fact-sheets/detail/radon-and-health (4.11.2021)
• ^[5] Darby S, Hill D, Auvinen A, Barros-Dios J, Baysson H, Bochicchio F, et al. Radon in homes and risk of lung cancer: Collaborative analysis of individual data from 13 European case-control studies. BMJ 2005; 330: 223-237. doi:10.1136/bmj.38308.477650.63
• ^[6] Sources-to-effects assessment for radon in homes and workplaces. United Nations Scientific Committee on the Effects of Atomic Radiation, 2009. UNSCEAR 2006 Report to the General Assembly with Scientific Annexes. Volume II, Annex E, 197-334. https://www.unscear.org/unscear/uploads/documents/unscear-reports/UNSCEAR_2006_Report_Vol.II.pdf (23.09.2025)
• ^[7] Strategi for å redusere radoneksponeringen i Norge. Oslo: Departementene, 2009. https://www.regjeringen.no/globalassets/upload/hod/dokumenter-fha/strategi-for-a-redusere-radoneksponeringen-i-norge.pdf (13.12.2021)
• ^[8] Evaluering av nasjonal radonstrategi 2009–2020. DSA-rapport 11:2020. Østerås: Direktoratet for strålevern og atomsikkerhet, 2020. https://www.dsa.no/publikasjoner/dsa-rapport-11-2020-evaluering-av-nasjonal-radonstrategi-2009-2020/DSA-rapport%2011-2020%20Evaluering%20av%20radonstrategien.pdf (23.09.2025)
• ^[9] Integrated Regulatory Review Service (IRRS) Mission to Kingdom of Norway. IAEA-NS-IRRS- 2019/04. The International Atomic Energy Agency: Department of Nuclear Safety and Security, 2019. https://www.iaea.org/sites/default/files/documents/review-missions/irrs_norway_2019.pdf (13.12.2021)
• ^[10] GBD results tool. Global Health Data Exchange. http://www.healthdata.org/results/gbd_summaries/2019/residential-radon-level-3-risk (13.12.2021)
• ^[11] Radiation Protection and Safety of Radiation Sources: International Basic Safety Standards. The International Atomic Energy Agency, Vienna, 2014. https://www-pub.iaea.org/MTCD/Publications/PDF/Pub1578_web-57265295.pdf (13.12.2021)
• ^[12] Europe’s Beating Cancer Plan. European Commission, 2021. >https://ec.europa.eu/health/sites/default/files/non_communicable_diseases/docs/eu_cancer-plan_en.pdf (13.12.2021)
• ^[13] COUNCIL DIRECTIVE 2013/59/EURATOM of 5 December 2013 laying down basic safety standards for protection against the dangers arising from exposure to ionising radiation, and repealing Directives 89/618/Euratom, 90/641/Euratom, 96/29/Euratom, 97/43/Euratom and 2003/122/Euratom. European Commission, 2014. https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:32013L0059&from=EN (13.12.2021)
• ^[14] Meld. St. 19 (2018–2019) Folkehelsemeldinga – Gode liv i eit trygt samfunn. Helse og omsorgsdepartementet. https://www.regjeringen.no/no/dokumenter/meld.-st.-19-20182019/id2639770/ (13.12.2021)
• ^[15] Innspill fra interessenter. Oppsummering av interessentinnspill til ny nasjonal radonstrategi. Notat fra Direktoratet for strålevern og atomsikkerhet, 21.05.2021, (ikke publisert).
• ^[16] Kreft i Norge: — kostnader for pasientene, helsetjenesten og samfunnet. En undersøkelse basert på data fra norske helseregistre. Oslo: Oslo Economics, 2016. https://osloeconomics.no/wp-content/uploads/2022/02/Kreftkostnader-i-Norge-Oslo-Economics.pdf (23.09.2025)
• ^[17] Samfunnskostnader knyttet til radonindusert lungekreft. Utarbeidet for Direktoratet for strålevern og atomsikkerhet. Oslo: Oslo Economics, februar 2022.
• ^[18] Varighet av radonreduserende tiltak i boliger 15 år etter tiltak. DSA-rapport 1:2019. Østerås: Direktoratet for strålevern og atomsikkerhet, 2019. https://dsa.no/publikasjoner/dsa-rapport-1-2019-varighet-av-radonreduserende-tiltak-i-boliger-15-ar-etter-tiltak/DSA-rapport%2001-2019%20radonreduserende%20tiltak.pdf (13.12.2021)
• ^[19] Gray A, Read S, McGale P, Darby S. Lung cancer deaths from indoor radon and the cost effectiveness and potential of policies to reduce them. BMJ 2009; 338: a3110. doi: 10.1136/bmj.a3110
• ^[20] Svensson M, Barregård L, Axelsson G, Andersson E. A cost-effectiveness analysis of lowering residential radon levels in Sweden-Results from a modelling study. Health Policy, 2018 Jun;122(6):687-692. doi: 10.1016/j.healthpol.2018.03.009
• ^[21] Stigum H, Strand T, Magnus P. Should radon be reduced in homes? A cost-effect analysis. Health Phys 2003 Feb;84(2):227-35. doi: 10.1097/00004032-200302000-00011
• ^[22] Arbeidstilsynet, nettside. Radon. https://www.arbeidstilsynet.no/tema/straling/radon/ (17.01.2024)